- Home
- CRWS vs MRSN Comparison
CRWS vs MRSN Comparison
Compare CRWS & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRWS
- MRSN
- Stock Information
- Founded
- CRWS 1957
- MRSN 2001
- Country
- CRWS United States
- MRSN United States
- Employees
- CRWS N/A
- MRSN N/A
- Industry
- CRWS Textiles
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- CRWS Consumer Discretionary
- MRSN Health Care
- Exchange
- CRWS Nasdaq
- MRSN Nasdaq
- Market Cap
- CRWS 34.0M
- MRSN 40.7M
- IPO Year
- CRWS N/A
- MRSN 2017
- Fundamental
- Price
- CRWS $3.20
- MRSN $0.36
- Analyst Decision
- CRWS
- MRSN Buy
- Analyst Count
- CRWS 0
- MRSN 3
- Target Price
- CRWS N/A
- MRSN $4.00
- AVG Volume (30 Days)
- CRWS 19.1K
- MRSN 2.2M
- Earning Date
- CRWS 06-27-2025
- MRSN 05-15-2025
- Dividend Yield
- CRWS 9.89%
- MRSN N/A
- EPS Growth
- CRWS N/A
- MRSN N/A
- EPS
- CRWS 0.24
- MRSN N/A
- Revenue
- CRWS $86,602,000.00
- MRSN $40,497,000.00
- Revenue This Year
- CRWS N/A
- MRSN N/A
- Revenue Next Year
- CRWS N/A
- MRSN N/A
- P/E Ratio
- CRWS $13.40
- MRSN N/A
- Revenue Growth
- CRWS N/A
- MRSN 9.88
- 52 Week Low
- CRWS $2.80
- MRSN $0.26
- 52 Week High
- CRWS $5.35
- MRSN $3.50
- Technical
- Relative Strength Index (RSI)
- CRWS 54.95
- MRSN 48.55
- Support Level
- CRWS $2.95
- MRSN $0.31
- Resistance Level
- CRWS $3.15
- MRSN $0.44
- Average True Range (ATR)
- CRWS 0.11
- MRSN 0.04
- MACD
- CRWS 0.06
- MRSN 0.00
- Stochastic Oscillator
- CRWS 78.79
- MRSN 37.46
About CRWS Crown Crafts Inc
Crown Crafts Inc operates in the infant and toddler products segment of the consumer products industry through its wholly-owned subsidiaries. The infant and toddler products segment consists of infant and toddler bedding, bibs, soft bath products, disposable products, and accessories. The company serves a diverse range of customers including mass merchants, mid-tier retailers, juvenile specialty stores, value channel stores, grocery and drug stores, restaurants, internet accounts, wholesale clubs, and internet-based retailers. The company's brands include NoJo, Neat Solutions, Sassy, and Carousel. Its products are marketed under a variety of company-owned trademarks, under trademarks licensed from others, and as private-label goods.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.